StockWatch
·
HomeLiveReports
Biotechnology: Biological Products (No Diagnostic Substances)
Board MeetingJul 28, 2026, 04:04 PM

Kymera Therapeutics Q2 2026 Earnings Call Scheduled for Aug 5

AI Summary

Kymera Therapeutics, Inc. announced it will report its second quarter 2026 financial results on August 5, 2026. The clinical-stage biopharmaceutical company will host a video conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. A replay of the webcast will be available following the event.

Key Highlights

  • Kymera Therapeutics will report second quarter 2026 financial results on August 5, 2026.
  • The company will host a video conference call and webcast at 8:30 a.m. ET on August 5, 2026.
  • Investors can register for the video call or view the livestreamed webcast via a provided link or the company's website.
  • A replay of the webcast will be archived and available after the event.
View SEC Filing
KYMR
Biotechnology: Biological Products (No Diagnostic Substances)
Kymera Therapeutics, Inc.

Price Impact

More from KYMR

Quarterly ResultAug 5, 7:22 AM

Kymera Q2 Net Loss $(61.2M), Revenue $65M; H1 Loss $(130.4M)

Quarterly ResultAug 5, 7:16 AM

Kymera Therapeutics Q2 Net Loss $61.2M; KT-621 AD Trial Ahead of Schedule

Management ChangeJul 27, 4:16 PM

Kymera Therapeutics Appoints Dr. Terence Rooney as New CMO

More in Board Meeting

NBPAug 13, 5:02 PM

NovaBridge Biosciences to Host Webcast for H1 2026 Results

LFVNAug 13, 4:33 PM

LifeVantage Schedules Q4 & Full Fiscal Year 2026 Earnings Call

AVALAug 13, 4:17 PM

Grupo Aval Q2 2026 Results Materials Available; Call Scheduled